FREDERICK, MD. October 14, 2015 — BioElectronics Corporation (OTC Pink: BIEL), maker of consumer medical electronics products for pain management endorsed the U.S. Food and Drug Administration’s final rule 890.5290 on nonthermal pulsed shortwave devices published today in the Federal Register. “I am pleased the agency has completed this step in streamlining the regulatory requirements … Continue Reading
BioElectronics Supports Arthritis Campaign
Osteoarthritis is the Most Common Cause of Disability FREDERICK, MD. September 21, 2015 — BioElectronics Corporation (OTC Pink: BIEL), maker of consumer medical electronics products for pain management, announced that they are sponsoring the Arthritis Care Time for Tea campaign October 12-18, 2015. Time for Tea is organized by Arthritis Care, a registered UK charity … Continue Reading
BioElectronics Selected to Present its Pain Research and Devices at the European Pain Federation Conference
FREDERICK, MD, USA, August 27, 2015 — BioElectronics Corporation (OTC Pink: BIEL), the maker of advanced consumer medical devices, announced today that three abstracts featuring the use of ActiPatch®, its novel musculoskeletal pain therapy, will be presented at the 9th Congress of the European Pain Federation EFIC®, Vienna, Austria, 2-5th September 2015. The Company will … Continue Reading
BioElectronics Reports Stronger Second Quarter Results
Publishes Market Analysis of its Try & Tell Survey That Predicts Strong Ongoing Sales
FREDERICK, MD, USA, August 18, 2015 — BioElectronics Corporation (OTC Pink: BIEL), the maker of advanced drug-free consumer medical devices, today published on its second quarter financial results along with a market analysis of its long term follow up surveys of customers who are managing pain with ActiPatch Therapy.
BioElectronics Files FDA Premarket Notification for ActiPatch® Therapy
The Most Innovative Treatment for Chronic Pain FREDERICK, MD. August 10, 2015 — BioElectronics Corporation (OTC Pink: BIEL), maker of consumer medical electronics products for pain management, announced the filing of a 510(k) Premarket Notification for ActiPatch® Therapy with the U.S. Food and Drug Administration. The market clearance request is for the adjunctive treatment of … Continue Reading
BioElectronics’ Landmark 5,000+ Chronic Pain Patient Study Published in Pain Management Medical Journal
FREDERICK, MD, USA, August 4, 2015 — BioElectronics Corporation (OTC Pink: BIEL), the maker of drug-free over-the-counter ActiPatch® Musculoskeletal Pain Therapy medical devices, announced today that its registry study of 44,000 users of its ActiPatch 7-day trial device has been published in the prominent peer reviewed medical journal Pain Management http://www.futuremedicine.com/doi/full/10.2217/PMT.15.35. More than 5,000 chronic … Continue Reading
UpTick News Wire Radio Show Will Interview BioElectronics’ CEO Andrew Whelan
Topics will Include UK Progress and New Clinical Publications FREDERICK, MD. August 3, 2015 — BioElectronics Corporation (OTC Pink: BIEL), maker of consumer medical electronics products for pain management announced that Andrew J. Whelan, President will be interviewed by Stu Taylor on his program “On Business“ at 9am EST on Wednesday, August 5th. Listen to … Continue Reading
BioElectronics Expands Medical and OTC Distribution
Appoints Market Leader, Medikon, LTD as distributor in Turkey FREDERICK, MD, USA, March 23, 2015 — BioElectronics Corporation (OTC Pink: BIEL), the maker of advanced medical devices, announced today that it has signed Medikon, one of the country’s leading medical suppliers as the distributor for RecoveryRx® Therapy for post-operative and chronic wound care, ActiPatch® Musculoskeletal … Continue Reading
BioElectronics Executive Vice President Dr. Deepak Kotak Interviewed on CEOLive.TV – Explains the Changing Paradigm of Chronic Pain
FREDERICK, MD, USA, February 9, 2015 — BioElectronics Corporation (OTC: BIEL), the maker of an industry leading family of bioelectric pain therapy devices, said today that its Executive Vice President, Dr. Deepak Kotak, was interviewed by CEOLIVE.TV as part of its Executive Interview Series. The entire interview is available at http://ceolive.tv/bioelectronics/biel-videos/2515-ceolive-tv-interview-dr-deepak-kotak-vp-of-bioelectronics-corp-biel In the interview, Dr. … Continue Reading
BioElectronics’ ActiPatch® Actual-Use Survey Finds 90% Have Excellent Chronic Pain Management and 88% had a Decrease in Opioid Use
FREDERICK, MD, USA, February 4, 2015– BioElectronics Corporation (OTC Pink: BIEL), the maker of advanced drug-free consumer medical devices, today released analysis of its ongoing and second long term follow up survey of customers in the United Kingdom and Ireland who are managing chronic pain with ActiPatch® Therapy, and reducing their dependence on systemic pain … Continue Reading